Mortality Benefit of Alirocumab: A Bayesian Perspective.

However, because of the hierarchical testing strategy used for the multiple outcomes examined, the observed reduction in all‐cause mortality was labeled “nominally significant” which has clouded its interpretation.

also in 7,732 other papers